Cellicure Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Cellicure General Information

Description

Operator of a drug research and development company intended to focus on the field of cellular immunotherapy. The company conducts global product development and commercialization for the highly unmet clinical needs caused by cancer, infectious diseases, and chronic inflammatory diseases, enabling patients with cell-based cancer cures for solid tumors and hematological malignancies.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 20400 Century Boulevard
  • Suite 280
  • Germantown, MD 20874
  • United States
+1 (301)
Primary Industry
Drug Discovery
Vertical(s)
Corporate Office
  • 20400 Century Boulevard
  • Suite 280
  • Germantown, MD 20874
  • United States
+1 (301)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cellicure Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 30-Jul-2026 Completed Out of Business
2. Early Stage VC (Series A) 09-May-2022 Completed Generating Revenue
1. Seed Round 01-Jul-2021 $1.5M $1.5M Completed Generating Revenue
To view Cellicure’s complete valuation and funding history, request access »

Cellicure Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series Pre-A
Seed
To view Cellicure’s complete cap table history, request access »

Cellicure Patents

Cellicure Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2024206549-A2 Engineered immune cells and use thereof Inactive 29-Mar-2023
WO-2024206549-A3 Engineered immune cells and use thereof Inactive 29-Mar-2023
US-20260083845-A1 Engineered immune cells Pending 23-Sep-2022
WO-2024064855-A2 Engineered immune cells Inactive 23-Sep-2022
WO-2024064855-A3 Engineered immune cells Inactive 23-Sep-2022 A61K40/15
To view Cellicure’s complete patent history, request access »

Cellicure FAQs

  • When was Cellicure founded?

    Cellicure was founded in 2021.

  • Where is Cellicure headquartered?

    Cellicure is headquartered in Germantown, MD.

  • What industry is Cellicure in?

    Cellicure’s primary industry is Drug Discovery.

  • Is Cellicure a private or public company?

    Cellicure is a Private company.

  • What is Cellicure’s current revenue?

    The current revenue for Cellicure is .

  • How much funding has Cellicure raised over time?

    Cellicure has raised $5.4M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process